She demonstrated a rapid response to therapies, with resolution of anemia and thrombocytopenia within 1 week and normalization of ADAMTS13 activity within 2 weeks and resolving hemolysis over the following weeks. Here, ADAMTS13 is linked to Thrombocytopenia.